article · Advances in Human Biology
Abstract Introduction: Non-prescription sale of controlled medicines is a growing public health problem, especially amongst low-middle-income countries, not helped by weak regulatory enforcement. Consequently, controlled medicines continue to be purchased without a prescription, exacerbating misuse and increasing morbidity and mortality. Currently, little is known about this in Pakistan. Therefore, this study aimed to evaluate the prevalence of non-prescription dispensing of controlled medicines in Pakistan. Materials and Methods: A multicentre, cross-sectional study using simulated clients (SC) was conducted in Lahore, Pakistan. SC visited 378 drug outlets (285 pharmacies and 93 medical stores) to purchase controlled medicines without providing a prescription. Data about dispensing, interactions and grounds for refusal were acquired. Results: About 61.9% of outlets dispensed controlled medicines without a prescription. The most commonly dispensed controlled medicines were tramadol (29.5%), followed by codeine (26.1%) and alprazolam (23.1%). There was no significant difference in non-prescription dispensing between pharmacies and medical stores. However, outlets lacking licenced personnel were significantly more likely to dispense controlled drugs without a prescription ( P = 0.049). Refusals were mainly due to prescription requirements (55.6%) or product unavailability (44.4%). Conclusions: There was appreciable dispensing of controlled medicines without a prescription, greater when licenced personnel were not present. Enhanced regulatory enforcement and increased presence of certified personnel are necessary going forward.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/aihb.aihb_280_25
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.